BSE:533210

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Kriti Nutrients Limited engages in the processing, extraction, and production of soya crude/refined oils and products under the KRITI brand in India. More Details


Snowflake Analysis

Flawless balance sheet with outstanding track record.


Similar Companies

Share Price & News

How has Kriti Nutrients's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 533210's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0.1%

533210

-0.1%

IN Food

-0.5%

IN Market


1 Year Return

108.9%

533210

12.5%

IN Food

2.0%

IN Market

Return vs Industry: 533210 exceeded the Indian Food industry which returned 12.5% over the past year.

Return vs Market: 533210 exceeded the Indian Market which returned 2% over the past year.


Shareholder returns

533210IndustryMarket
7 Day0.1%-0.1%-0.5%
30 Day8.2%-4.1%0.3%
90 Day27.2%0.6%7.1%
1 Year110.2%108.9%14.0%12.5%3.7%2.0%
3 Year46.8%43.5%39.2%34.8%2.0%-3.0%
5 Year150.9%141.8%130.1%118.9%40.9%30.4%

Price Volatility Vs. Market

How volatile is Kriti Nutrients's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Kriti Nutrients undervalued compared to its fair value and its price relative to the market?

8.04x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 533210 (₹37.6) is trading above our estimate of fair value (₹23.06)

Significantly Below Fair Value: 533210 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 533210 is good value based on its PE Ratio (8x) compared to the IN Food industry average (13.4x).

PE vs Market: 533210 is good value based on its PE Ratio (8x) compared to the Indian market (16.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 533210's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 533210 is overvalued based on its PB Ratio (2.2x) compared to the IN Food industry average (1.1x).


Next Steps

Future Growth

How is Kriti Nutrients forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.4%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kriti Nutrients has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Kriti Nutrients performed over the past 5 years?

26.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 533210 has high quality earnings.

Growing Profit Margin: 533210's current net profit margins (4.3%) are higher than last year (3%).


Past Earnings Growth Analysis

Earnings Trend: 533210's earnings have grown significantly by 26.2% per year over the past 5 years.

Accelerating Growth: 533210's earnings growth over the past year (59.3%) exceeds its 5-year average (26.2% per year).

Earnings vs Industry: 533210 earnings growth over the past year (59.3%) exceeded the Food industry 16.7%.


Return on Equity

High ROE: 533210's Return on Equity (26.9%) is considered high.


Next Steps

Financial Health

How is Kriti Nutrients's financial position?


Financial Position Analysis

Short Term Liabilities: 533210's short term assets (₹728.6M) exceed its short term liabilities (₹322.2M).

Long Term Liabilities: 533210's short term assets (₹728.6M) exceed its long term liabilities (₹82.6M).


Debt to Equity History and Analysis

Debt Level: 533210's debt to equity ratio (7.1%) is considered satisfactory.

Reducing Debt: 533210's debt to equity ratio has reduced from 81.2% to 7.1% over the past 5 years.

Debt Coverage: 533210's debt is well covered by operating cash flow (216.6%).

Interest Coverage: 533210 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Kriti Nutrients's current dividend yield, its reliability and sustainability?

0.48%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 533210's dividend (0.48%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.57%).

High Dividend: 533210's dividend (0.48%) is low compared to the top 25% of dividend payers in the Indian market (2.28%).


Stability and Growth of Payments

Stable Dividend: 533210 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 533210's dividend payments have increased, but the company has only paid a dividend for 9 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (3.9%), 533210's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.8yrs

Average board tenure


CEO

Shiv Mehta (66 yo)

no data

Tenure

₹4,782,000

Compensation

Mr. Shiv Singh Mehta, B.E., MBA is a Co-Founder of Kriti Industries (India) Ltd. and serves as its Managing Director. Mr. Mehta serves as Managing Director of Kriti Nutrients Ltd. He has been Executive Cha ...


CEO Compensation Analysis

Compensation vs Market: Shiv's total compensation ($USD65.07K) is about average for companies of similar size in the Indian market ($USD55.25K).

Compensation vs Earnings: Insufficient data to compare Shiv's compensation with company performance.


Board Members

NamePositionTenureCompensationOwnership
Shiv Mehta
Executive Chairman & MDno data₹4.78m4.15%
₹ 78.1m
Saurabh Mehta
Whole-Time Director10.83yrs₹11.38m0.061%
₹ 1.1m
Rakesh Kalra
Independent & Non-Executive Director6.75yrs₹104.00kno data
Purnima Mehta
Non-Executive Independent Director10.83yrs₹104.00k0.26%
₹ 4.9m
Manoj Fadnis
Independent Non-Executive Director10.83yrs₹104.00kno data
Chandrasekharan Bhaskar
Independent Director1.42yrs₹60.00kno data

8.8yrs

Average Tenure

62.5yo

Average Age

Experienced Board: 533210's board of directors are considered experienced (8.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Kriti Nutrients Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Kriti Nutrients Limited
  • Ticker: 533210
  • Exchange: BSE
  • Founded: 1992
  • Industry: Packaged Foods and Meats
  • Sector: Food, Beverage & Tobacco
  • Market Cap: ₹1.884b
  • Shares outstanding: 50.10m
  • Website: https://kritinutrients.com

Number of Employees


Location

  • Kriti Nutrients Limited
  • Brilliant Sapphire
  • 801–804, 8th Floor
  • Indore
  • Madhya Pradesh
  • 452 010
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
533210BSE (Mumbai Stock Exchange)YesEquity SharesININRJun 2010

Biography

Kriti Nutrients Limited engages in the processing, extraction, and production of soya crude/refined oils and products under the KRITI brand in India. It offers soya proteins, soya lecithin, soya oils, soya ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/21 13:09
End of Day Share Price2020/10/21 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.